针对尿失禁妇女的网络干预措施的有效性:随机对照试验的系统审查和元分析的协议
Xuefen Xu1, Pingping Guo1, Ping Xu1
1Women's Hospital School of Medicine Zhejiang University, Hangzhou, Zhejiang, China.
BMJ open
|March 29, 2024
概括
本综述探讨了女性尿失禁的网络干预措施. 研究结果将为最佳的数字健康策略提供信息,以改善症状严重程度和生活质量.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 数字健康数字健康
- 基于证据的医学基于证据的医学.
背景情况:
- 尿失禁 (UI) 严重影响妇女的健康,并造成社会成本.
- 基于Web的干预措施 (WBI) 显示了管理UI的潜力,但它们的有效性需要进一步研究.
研究的目的:
- 系统地审查和元分析WBIs对UI妇女的有效性.
- 评估对症状严重程度,生活质量和坚持盆地肌肉训练的影响.
- 探索干预特征如何影响WBI有效性.
主要方法:
- 系统审查和元分析协议遵循PRISMA指南.
- 在2024年5月1日之前,对10个电子数据库和灰色文献进行全面搜索.
- 使用Cochrane工具进行偏差风险评估; Stata中的元分析;敏感性和子组分析.
主要成果:
- (结果尚未提供,因为这是一个协议)
结论:
- (结论尚未提供,因为这是一个协议)
- 这些发现将指导优化WBI的开发,以帮助UI的女性.
- 通过同行评审的出版物和会议演讲计划传播.
更多相关视频
03:30Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
Published on: October 25, 2024
1.5K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
166
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166
Irritable Bowel Syndrome III: Medical and Nursing Management
201
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
201
